Abdominal aortic aneurysm; 18F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/ computed tomography Abstract Objectives: Abdominal aortic aneurysms (AAAs) are associated with an inflammatory cell infiltrate and enzymatic degradation of the vessel wall. The aim of this study was to detect increased metabolic activity in the wall of the AAA with 18F-fluorodeoxyglucose ( 18 F-FDG), mediated by glucose transporter protein (GLUTs), using a dedicated hybrid PET/64-detector CT. Design, method and materials: 14 patients (All male, mean age 73.6 years, range 61e82) with AAA under surveillance underwent PET/CT scanning with 175 MBq of intravenous I8 F-FDG. The maximum aneurysm diameter and calcification score were determined on the attenuation correction CT. A volume of interest was placed on the aneurysm sac and the maximum Standardised Uptake Value (SUV max ) measured. Results: The mean aneurysm diameter was 5.4 cm (SD AE 0.8). Two aneurysms had the CT characteristics of inflammatory aneurysms. Twelve aneurysms showed increased FDG uptake (SUV max > 2.5). There was no significant difference in FDG uptake between heavily calcified aneurysms and non-heavily calcified aneurysms (t-test). There was a significant increase in the FDG uptake in the two inflammatory aneurysms compared to the other twelve aneurysms (t-test; P Z 0.04).
Introduction
Abdominal aortic aneurysm (AAA) diameter is an important predictor of risk of aneurysm rupture. 1, 2 However, some aneurysms rupture at a small size, 2e4 and many large aneurysms grow to a considerable size without rupture. Size therefore is not the only determinant for the risk of rupture. Investigators have shown that anatomical and dynamic features such as, aneurysm shape, aneurysm wall calcification and computed wall stress, are also associated with the risk of AAA rupture. 5, 6 AAAs are associated with an inflammatory cell infiltrate and enzymatic degradation of the vessel wall.
7e9 Correlation between risk of rupture and biological markers of inflammation has been demonstrated. 10 Furthermore, immune-mediated processes play a role in initiation of AAA disease and rupture. 11e13 In their immunohistochemical study, Mochizuki et al. reported that the expression of glucose transporter protein (GLUTs) was detected in inflammatory tissue, which showed [14C]FDG uptake higher than that of normal control muscle. 14 18 F-FDG accumulates in macrophage-rich atherosclerotic plaques and demonstrates that vascular macrophage activity can be quantified non-invasively. 15 Investigators have shown that 18 F-FDG positron emission tomography (PET) can reliably detect inflammation in atherosclerosis. 16 Recently, Reeps et al. confirmed accurate detection of vascular inflammation by PET/CT by demonstrating correlation between histologically assessed macrophage-dense regions and FDG uptake (r Z 0.93, P < 0.0001). 17 In contrast to studies on plaque, a previous study using PET has shown an increased FDG uptake in only 39% of aneurysms. 7 However, this study assessed larger-size AAAs (mean AAA diameter 6.3 AE 0.95 cm) with a PET only scanner. During hybrid PET/CT, an attenuation correction CT is performed, immediately followed by an 18 F-FDG PET emission scan, whilst maintaining the same patient position. The hybrid PET/64-detector CT scanner allows a more reliable assessment of increased FDG uptake in areas of interest on a high resolution CT.
Understanding the degree of inflammation and associations in small AAAs as assessed by hybrid PET/CT may become increasingly relevant with the implementation of aneurysm screening.
Preliminary data shows focal uptake of 18 F-FDG within the aneurysm wall in patients with large, rapidly expanding or symptomatic aneurysms that are prone to rupture. 18 However, the role of hybrid PET/CT, especially in quantifying the degree of inflammation in patients with small AAAs under surveillance, remains to be defined.
The aim of this preliminary study was to detect increased metabolic activity in AAAs of patients undergoing surveillance, with FDG-PET/CT. Furthermore this prospective study assesses the possible association between aneurysm wall calcification, expansion rate, and increased FDG Uptake. Detection of inflammation with hybrid PET/CT in the aneurysm walls may help predict growth rate and allow evaluation of pharmacological interventions for suppression of inflammation in small aneurysms.
Material and Methods

Patients
A total of 14 patients (all men) with a mean age of 73.6 years (range 61e82) were prospectively studied. All patients had infra-renal AAAs and the study group included twelve small AAAs (<5.5 cm) and two larger-size AAAs (as measured by ultrasound scan). One of the fourteen patients was symptomatic and underwent an EVAR (Endovascular aneurysm repair). This patient had a large (6.7 cm) juxta-renal inflammatory abdominal aortic aneurysm (IAAA) and presented with associated back pain. The mean maximum aneurysm diameter in the population studied was 5.4 cm (SD AE 0.8 cm). Each patient underwent an ultrasound scan followed by PET/CT within two weeks of the ultrasound scan, between December 2007 and February 2008. Exclusion criteria for the study were the presence of congestive heart failure and/or impaired renal function (serum creatinine > 1.8 mg/dL). Ethics approval was obtained from the University College London Research Ethics committee and regional site specific approval was obtained from the Brighton & Mid Sussex Research Ethics committee. All subjects provided written informed consent. Patient characteristics for co-morbidities and oral medications are documented in Table 1 . Study population data for patients with non-specific AAAs, undergoing surveillance, is summarized in Table 2 .
Protocol for ultrasound surveillance
All patients underwent ultrasound scans to measure the size of the aneurysm at intervals of 3, 6 or 12 months. All scans were performed in the same unit by experienced Vascular Scientists using standard protocol and equipment.
Protocol for FDG-PET/CT
Patients were instructed to fast for at least 6 h prior to the FDG-PET/CT. In keeping with recommendations from other cardiovascular PET studies 19, 20 images were acquired from a single bed position 3 h after injecting 175 MBq of 18 F-FDG using a dedicated combined PET/64-detector CT instrument (GE Healthcare Technology, Waukesha, WI). Firstly, an attenuation correction CT was performed using 64 Â 3.75-mm detectors, a pitch of 1.5 and a 5-mm collimation (140 kVp and 80 mA in 0.8 s) over the patient's abdominal aorta. Maintaining the patient position, an 18 F-FDG PET emission scan was performed and covered an area identical to that covered by CT. All acquisitions were carried out in 2D mode (8 min/bed position). Trans-axial emission images of 3.27 mm thickness (pixel size 3.9 mm) were reconstructed using ordered subsets expectation maximisation (OSEM) with two iterations and 28 subsets. The axial field of view was 148.75 mm, resulting in 47 slices per bed position.
Image analysis
PET/CT images were reviewed by two combined radiologist/nuclear medicine physicians in consensus. One of these readers had a specialist interest in cardiothoracic PET/CT (more than 5 years). PET/CT images were loaded onto a Xeleris workstation (GE Healthcare Technology, Waukesha, WI). The maximum aneurysm diameter and aneurysmal calcification score were determined on the attenuation correction CT.
A volume of interest was placed on the aneurysmal sac (i.e. an area of most intense aortic wall 18 F-FDG uptake) and the maximum Standardised Uptake Value (SUV max ) measured (Fig. 1) .
Statistical analysis
Data analysis was carried out using the statistical package SPSS â version 15.0 for Windows. Unpaired t-test was used for comparison of FDG uptake and the following groups: IAAAs and non-IAAAs; heavily calcified AAAs (calcification score > 10,000) and non-heavily calcified AAAs. The relationship between increased FDG uptake and annual expansion was analyzed with Spearman rank correlation. A P value of less than 0.05 was considered statistically significant and SUV values were calculated as mean AE standard deviation. 
Results
Two patients had CT characteristics of inflammatory AAA (IAAA), defined by peri-aortic fibrosis of well-defined soft tissue density with involvement of adjacent retroperitoneal structures. 21 These two patients, aged 62 and 66 years, both presented with associated back pain and AAAs that measured 4.8 cm and 6.7 cm on ultrasound respectively. Recent AAA expansion within the last year as measured by ultrasound was seen in seven patients. Recent annual expansion 3 mm were observed in three patients and three patients had a recent annual growth rate >3 mm and <6 mm (including one IAAA). Two patients presented with an expansion >6 mm in the last year. The mean aneurysm calcification score was 7973 (SD AE 6980). Four aneurysms were heavily calcified with scores >10,000.
Relationship between clinical characteristics and 18 F-FDG uptake
Twelve aneurysms showed an increased FDG uptake (SUV max > 2.5). No significant correlation was found between the degree of FDG uptake and recent AAA growth rate (Spearman's correlation coefficient; r Z 0.18; P Z 0.60). Furthermore no association was observed between crosssectional infra-renal AAA diameter and SUV max . (Spearman's correlation coefficient; r Z À0.006; P Z 0.96). A more marked FDG uptake was observed in the two patients with IAAA, diagnosed on CT scan prior to PET/ CT. One of these patients was asymptomatic. There was a significant difference in the degree of FDG uptake between CT apparent inflammatory and non-specific aneurysms (Unpaired t-test, t Z 2.30, df Z 12, CI Z 0.11e 4.02, P Z 0.04). PET/CT revealed no other clinical findings. Furthermore, only two patients in our study revealed a SUV max < 2.5, of which one patient demonstrated a SUV value of 2.5.
Relationship between anatomical characteristics and 18 F-FDG uptake
There was no significant difference in FDG uptake between heavily calcified aneurysms and non-heavily calcified aneurysms (Unpaired t-test; t Z À1.48, df Z 12, CI Z À2.65e0.51, P Z 0.17).
Discussion
The use of FDG-PET/CT in vivo has previously been described in patients with symptomatic and/or large AAAs. 18 We evaluated the role of hybrid FDG-PET/CT to detect increased non-homogeneous metabolic activity in small AAAs, in patients undergoing surveillance.
Current pathological concepts suggest that chronic inflammation and enzymatic degradation play a role in AAA formation and rupture. 7, 12, 13 Histological findings suggest that IAAAs are the extreme end of an inflammatory process responsible for both the IAAAs and other unspecified AAAs. 22 This study shows that the majority (n Z 12) of patients demonstrated an increased FDG uptake (SUV max > 2.5) in the aneurysm wall. Inflammatory processes may, therefore, be present to some extent in most aneurysms. In contrast, a PET study by Sakalihasan et al. failed to confirm previous histological findings by reporting increased FDG in only 39% of their study population. 7 The study did not clearly define a positive PET finding, and positive PET findings may have been judged solely on appearance. Also patients with larger-size aneurysms were studied (mean AAA diameter 6.3 AE 0.95 cm) as compared to our study of smaller aneurysms (mean AAA diameter 5.4 AE 0.8 cm). Furthermore, the study performed PET independent from CT scan, whereas in our study hybrid PET/CT was used. The benefit of hybrid PET/CT over independent imaging modalities is described in the literature. 23 Combined PET/CT used in our study, eliminates the positional discrepancies and some of the challenges brought on by different test timings when interpreting investigation findings. Improved test sensitivity Figure 1 Axial PET image of the same abdominal aortic aneurysm as in Fig. 3 with Regions of Interest (ROI) placed on the lumen and the wall of the aorta. 
Difference in FDG Uptake between Inflammatory AAAs and Non-specific AAAs
IAAAs
Non-specific AAAs SUVmax Figure 2 Increased FDG uptake (SUV max > 2.5) compared in patients with an inflammatory abdominal aortic aneurysms (IAAAs) and those with non-specific AAAs. A significant difference between 18 F-FDG uptake in the walls of the inflammatory AAAs and non-specific AAAs is demonstrated (P Z 0.04).
due to technology and technique advances, may partly explain the higher global SUV max in our study.
The presence of increased FDG tracer intensity in IAAAs has been reported. 24 An area of most intense aortic wall 18 F-FDG uptake was determined for all the study patients in order to avoid false high SUV max values which could be reflected in IAAA patients due to peri-aortic metabolic or inflammatory processes. Our study suggests a significant difference between 18 F-FDG uptake in the walls of the inflammatory AAAs and non-specific AAAs (P Z 0.04) (Figs. 2e4) , but is based on very small numbers. The present study demonstrates an inhomogeneous degree of increased metabolic activity in the wall of most AAAs however we did not directly correlate this with inflammatory processes. Factors influencing AAA wall inflammatory processes require investigation and further prospective studies are necessary to establish the role of PET/CT in quantitative assessment of inflammation in AAAs and the clinical significance thereof.
Rapid expansion in large aneurysms and its association with increased FDG uptake were reported in a previous study. 17 In comparison, our study did not support this association. Irregular and unpredictable progression of small AAAs 25 and small patient numbers (n Z 14) could explain our results. The relationship between FDG uptake and AAA growth rate and risk of rupture in AAA under surveillance remains unanswered, although correlating focal increase in FDG uptake with histological findings from the rupture site may prove to be impossible. Maximal AAA diameter measured with CT is significantly and consistently larger than maximal AAA diameter measured with ultrasound. 26, 27 This explains the discrepancy seen in some of the maximal AAA measurements between ultrasound and CT displayed in this study. This study confirmed similar findings by another study in that no relationship between crosssectional infra-renal AAA diameter and increased aortic wall glucose metabolism was demonstrated 17 (Fig. 2) . A recent study suggests aneurysm wall stress to be more predictive of rupture risk than AAA diameter. 6 Further research is required to assess the relationship between increased glucose metabolism and increased AAA wall stress.
It is reported that the presence of calcification increases AAA peak wall stress, suggesting that calcification decreases the biomechanical stability of AAAs. 28 Another study showed that the FDG uptake site was mostly distinct from the calcification site and may possibly be located in areas of metabolic activity of atherosclerotic changes. 29 There was no correlation detected between Figure 3 Axial (a) Unenhanced CT, (b) PET, and (c) PET/CT fusion of an abdominal aortic aneurysm showing uptake in the lumen and increased uptake in the wall of the aorta, which is thickened, compatible with an inflammatory aneurysm. Two of the 14 cases were inflammatory AAAs.
increased FDG uptake and degree of calcification found (P Z 0.17). The authors agree that the clinical significance of the relationship between vascular-wall 18 F-FDG uptake and CT calcifications needs to be assessed by further prospective studies with long-term follow up. 20 Despite the improved reliability of integrated 64 slice PET/CT there are some limitations that need to be addressed. The partial volume effect observed in small thin targets such as the AAA wall may affect the accuracy of FDG-PET/CT. Results could be more accurate with the implementation of volume effect correction. Furthermore, differences in activity or volume could influence the accuracy of signal interpretation.
It is documented that various malignant tumors express increased GLUTs and it is suggested that increased GLUT expression contributes to increased FDG uptake in PET imaging. 24 The findings in this study offer in vivo evidence that AAA show increased glucose metabolism. Hybrid PET/CT may be a valuable assessment technique in identifying the role that increased metabolic activity and inflammation play in AAA disease. 
